<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00212680</url>
  </required_header>
  <id_info>
    <org_study_id>ONO-1101-1906</org_study_id>
    <nct_id>NCT00212680</nct_id>
  </id_info>
  <brief_title>Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan</brief_title>
  <official_title>Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in Japan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ono Pharma USA Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ono Pharmaceutical Co. Ltd</source>
  <brief_summary>
    <textblock>
      The purpose of this study was to evaluate the dose-dependent effects of ONO-1101 on efficacy
      and safety in patients with postoperative supraventricular tachyarrhythmias.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 1996</start_date>
  <primary_completion_date type="Actual">April 2006</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients achieving 20% reduction in heart rate at each dose</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart Rate, Blood pressure and 12-lead ECG</measure>
  </secondary_outcome>
  <enrollment>100</enrollment>
  <condition>Postoperative Supraventricular Tachyarrythmia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ONO-1101</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 20-80 years old

          2. Postoperative supraventricular tachyarrhythmias (sinus tachycardia, those with a heart
             rate of 120 beats/min or higher, and supraventricular arrhythmia, those with a heart
             rate of 100 beats/min or higher)

          3. Within 7 days postoperatively

          4. Other inclusion criteria as specified in the protocol

        Exclusion Criteria:

          1. Acute myocardial infarction (within 1 month after onset)

          2. Severe heart failure (New York Heart Association functional class III or higher)

          3. Atrioventricular block (grade II or higher),or sick sinus syndrome

          4. Other exclusion criteria as specified in the protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Project Leader, Development Planning</last_name>
    <role>Study Director</role>
    <affiliation>Ono Pharmaceutical Co. Ltd</affiliation>
  </overall_official>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 20, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>October 10, 2012</last_update_submitted>
  <last_update_submitted_qc>October 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ONO-1101,Landiolol Hydrochloride, Postoperative, Supraventricular Tachyarrhythmia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Landiolol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

